A NOGG threshold that characterises men and women at high and very high fracture risk has also been established using FRAX probabilities; very high risk is identified as a FRAX-based fracture probability that exceeds the intervention threshold by 60% (Figures 1 and 2) 137.

This page allows you to enter the FRAX fracture probabilities with some additional information (age, gender, glucocorticoid exposure and finally, whether a femoral neck BMD has been included in the FRAX estimates), so that the result can be automatically compared to the NOGG thresholds with appropriate guidance on treatment.

NOGG provides a clinical guideline that reviews the assessment and diagnosis of osteoporosis, the therapeutic interventions available and the approaches for the prevention of fragility fractures, in postmenopausal women, and in men aged 50 years or older.

A FRAX assessment should be performed in any postmenopausal woman, or man age ≥50 years, with a clinical risk factor for fragility fracture, to guide BMD measurement and prompt timely referral and/or drug treatment, where indicated (Strong recommendation).

Conduct a FRAX assessment in people with a clinical risk factor for fragility fracture. Measure BMD in people with intermediate fracture risk by FRAX (amber) to refine the estimate of 10-year risk.

FRAX Calculator; Manual Data Entry; Third Navigation. Information for Patients; Resource Centre; About NOGG

NOGG recommends the use of FRAX, which can be used with or without DXA results and calculates the 10-year probability of hip and major osteoporotic fracture (hip, spine, humerus or wrist). The results of FRAX are linked to NOGG treatment thresholds which guide management.

Welcome to the NOGG 2024 Guideline. These new thresholds ensure equality of access to treatment for older patients with and without fracture, and identify a group who are at very high fracture risk who should be considered for specialist referral (for full …

If BMD measurement is not practical (e.g. due to frailty), use the online NOGG intervention thresholds based on FRAX, to guide treatment decisions. 8. Consider, particularly in older people, drug treatment in those with a prior and/or recent fragility fracture.

Reassessment of fracture risk in treated individuals can be performed using FRAX with femoral neck BMD 149; (Evidence level IIb). The NOGG intervention thresholds can then be used to guide the decision as to whether treatment can be stopped for a period of time (Figures 4 and 5).